|Articles|October 1, 2018
- BioPharm International-10-01-2018
- Volume 31
- Issue 10
BioPharm International, October 2018 Issue (PDF)
Click the title above to open the BioPharm International October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
AAPS Traces the Path to ICH M10about 7 years ago
A Plastic Pipeline for Commercial Bioprocessing?about 7 years ago
Outsourcing Development: Small-Scale to Commercialabout 7 years ago
The Link Between Data Integrity and Quality Cultureabout 7 years ago
FDA Clarifies Worldwide Inspection PoliciesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
2
How Mitigation and Maintenance Protect Against Future Risk
3
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
4
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
5

